Zadik Hazan
Technik-/Wissenschafts-/F&E-Leiter bei Hy BioPharma, Inc.
Aktive Positionen von Zadik Hazan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Hy BioPharma, Inc.
 Hy BioPharma, Inc. Medical DistributorsDistribution Services Hy BioPharma, Inc. develops drug technology solutions. The company develops Hypericin for the treatment of cancer, autoimmune disorders, and inflammation. It was established in 2006 and is headquartered in Jamison, PA. | Technik-/Wissenschafts-/F&E-Leiter | 22.04.2009 | - |
Regenera Pharma Ltd.
 Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Direktor/Vorstandsmitglied | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Zadik Hazan
Statistik
International
| Vereinigte Staaten | 2 |
| Israel | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
Sektoral
| Distribution Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Hy BioPharma, Inc.
Hy BioPharma, Inc. Medical DistributorsDistribution Services Hy BioPharma, Inc. develops drug technology solutions. The company develops Hypericin for the treatment of cancer, autoimmune disorders, and inflammation. It was established in 2006 and is headquartered in Jamison, PA. | Distribution Services |
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Health Technology |
- Börse
- Insiders
- Zadik Hazan
- Erfahrung
